A homologous naturally occurring mutation in Duffy and CCR5 leading to reduced receptor expression

Blood

Volumn 97, Issue 11, 2001, Pages 3651-3654

  Tamasauskas, Daniel ^a,b   Powell, Vivien ^a,b   Saksela, Kalle ^a,b   Yazdanbakhsh, Karina ^a,b  

^a NEW YORK BLOOD CENTER   (United States)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHEMOKINE RECEPTOR CCR5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS;

EID: 0035383794     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3651     Document Type: Article

References (25)

1. Murphy PM, Baggiolini M, Charo IF, et al. International Union of Pharmacology, XXII: nomenclature for chemokine receptors. Pharmacol Rev. 2000;52:145-176.
2. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121-127.
3. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks: the Duffy-blood-group genotype, FyFy. N Engl J Med. 1976;295:302-304.
4. Pogo AO, Chaudhuri A. The Duffy protein: a malarial and chemokine receptor. Semin Hematol. 2000;37:122-129.
5. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study [see comments] [published erratum appears in Science. 1996;274:1069]. Science. 1996;273:1856-1862.
6. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367-377.
7. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382:722-725.
8. Zimmerman PA, Buckler-White A, Alkhatib G, et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med. 1997;3:23-36.
9. Roda Husman AM, Koot M, Cornelissen M, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med. 1997;127:882-890.
10. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med. 1997;3:338-340.
11. Yazdanbakhsh K, Rios M, Storry JR, et al. Molecular mechanisms that lead to reduced expression of Duffy antigens. Transfusion. 2000;40:310-320.
12. x individuals [erratum in Blood 2000;95:2753]. Blood. 1998;92:2147-2156.
13. b allele predicting Arg89Cys in the Duffy glycoprotein. Br J Haematol. 1998;103: 1184-1191.
14. Carrington M, Kissner T, Gerrard B, Ivanov S, O'Brien SJ, Dean M, Novel alleles of the chemokine-receptor gene CCR5. Am J Hum Genet. 1997;61:1261-1267.
15. Hodges RS, Heaton RJ, Parker JM, Molday L, Molday RS. Antigen-antibody interaction: synthetic peptides define linear antigenic determinants recognized by monoclonal antibodies directed to the cytoplasmic carboxyl terminus of rhodopsin. J Biol Chem. 1988;263:11768-11775.
16. Cypess AM, Unson CG, Wu CR, Sakmar TP. Two cytoplasmic loops of the glucagon receptor are required to elevate cAMP or intracellular calcium. J Biol Chem. 1999;274:19455-19464.
17. Donzella GA, Schols D, Lin SW, et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med. 1998;4:72-77.
18. Manninen A, Herma RG, Saksela K. Synergistic activation of NFAT by HIV-1 nef and the Ras/ MAPK pathway. J Biol Chem. 2000;275:16513-16517.
19. Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 1995;206:935-944.
20. Wasniowska K, Blanchard D, Janvier D, et al. Identification of the Fy6 epitope recognized by two monoclonal antibodies in the N-terminal extracellular portion of the Duffy antigen receptor for chemokines. Mol Immunol. 1996;33:917-923.
21. Lu ZH, Wang ZX, Horuk R, et al. The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. J Biol Chem. 1995;270:26239-26245.
22. Wu L, LaRosa G, Kassam N, et at. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med. 1997;186:1373-1381.
23. von Heijne G. Membrane protein structure prediction: hydrophobicity analysis and the positiveinside rule. J Mol Biol. 1992;225:487-494.
24. Blanpain C, Lee B, Tackoen M, et al. Multiple nonfunctional alleles of CCR5 are frequent in various human populations. Blood. 2000;96: 1638-1645.
25. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol. 1998;72:2855-2864.